1,147
Views
21
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Association between Periodontal Disease and Chronic Obstructive Pulmonary Disease: A Case Control Study

, , , , , , , & show all

References

  • Rabe KF, Hurd S, Anzueto A, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Critl Care Med 2007; 176:532–555.
  • Barnes PJ, Celli BR. Systemic manifestations and comorbities of COPD. Eur Respir J 2009; 33:1165–1185.
  • Agusti AGN, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003; 21:347–360.
  • Leuckfeld I, Obregon-Whittle MV, Lund MB, Geiran O, Bjørtuft Ø, Olsen I. Severe chronic obstructive pulmonary disease: association with marginal bone loss in periodontitis. Respir Med 2008; 102:488–494.
  • Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax 2004; 59:574–580.
  • Chen Y, Chen P, Hanaoka M, Droma Y, Kubo K. Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD. Respirology 2008; 13:1014–1021.
  • Scannapieco FA, Mylotte JM. Relationships between periodontal disease and bacterial pneumonia. J Periodontol 1996; 67(Suppl):1114–1122.
  • Zhong Y, Slade GD, Beck JD, Offenbacher S. Gingival crevicular fluid interleukin-1beta, prostaglandin E2 and periodontal status in a community population. J Clin Periodontol 2007; 34:285–293.
  • Offenbacher S, Heasman PA, Collins JG. Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol 1993; 64:432–444.
  • Engebretson SP, Grbic JT, Singer R, Lamster IB. GCF IL-1beta profiles in periodontal disease. J Clin Periodontol 2002; 29:48–53.
  • Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 1997; 14:33–53.
  • Nishimura F, Kono T, Fujimoto C, Iwamoto Y, Murayama Y. Negative effects of chronic inflammatory periodontal disease on diabetes mellitus. J Int Acad Periodontol 2000; 2:49–55.
  • Kuo LC, Polson AM, Kang T. Associations between periodontal diseases and systemic diseases: a review of the inter-relationships and interactions with diabetes, respiratory diseases, cardiovascular diseases and osteoporosis. Public Health 2008; 122:417–433.
  • Amar S, Han X. The impact of periodontal infection on systemic diseases. Med Sci Monit 2003; 9:291–299.
  • Hayes C, Sparrow D, Cohen M, Vokonas PS, Garcia RI. The association between alveolar bone loss and pulmonary function: the VA Dental Longitudinal Study. Ann Periodontol 1998; 3:257–261.
  • Scannapieco FA, Papandonatos GD, Dunford RG. Associations between oral conditions and respiratory disease in a national sample survey population. Ann Periodontol 1998; 3:251–256.
  • Scannapieco FA, Ho AW. Potential associations between chronic respiratory disease and periodontal disease: analysis of National Health and Nutrition Examination Survey III. J Periodontol 2001; 72:50–56.
  • Azarpazhooh A, Leake JL. Systematic review of the association between respiratory diseases and oral health. J Periodontol 2006; 77:1465–1482.
  • Silness J, Lˆe H. Periodontal diseases in pregnancy II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964; 22:121–135.
  • Lˆe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963; 25:533–548.
  • Zhou X, Wang Z, Song Y, Zhang J, Wang C. Periodontal health and quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2011; 105:67–73.
  • Wang Z, Zhou X, Zhang J, Zhang L, Song Y, Hu FB. Periodontal health, oral health behaviors, and chronic obstructive pulmonary disease. J Clin Periodontol 2009; 36:750–755.
  • Liu Z, Zhang W, Zhang J, Oral hygiene, periodontal health and chronic obstructive pulmonary disease exacerbations. J Clin Periodontol 2012; 39:45–52.
  • Kucukcoskun M, Baser U, Oztekin G, Kiyan E, Yalcin F. Initial periodontal treatment for prevention of chronic obstructive pulmonary disease exacerbations. J Periodontol 2013; 84:1983–1990.
  • Rees TD. Periodontal management of the patient with diabetes mellitus. Periodontol 2000; 23:63–72.
  • Botero JE, Yepes FL, Rold·n N, Tooth and periodontal clinical attachment loss are associated with hyperglycemia in diabetic patients. J Periodontol 2012; 83:1245–1250.
  • Hyman, J. The importance of assessing confounding and effect modication in research involving periodontal disease and systemic diseases. J Clin Periodontol 2006; 33:102–103.
  • Zhou X, Wang Z, Song Y, Zhang J, Wang C. Periodontal health and quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2011; 105:67–73.
  • Zhang L, Lou P, Zhu Y, Impact of risk factors, activities and psychological disorders on the health of patients with chronic obstructive pulmonary disease in China: a cross-sectional study. BMC Public Health 2013; 13:627.
  • Katancik JA, Kritchevsky S, Weyant RJ, Periodontitis and airway obstruction. J Periodontol 2005; 76(11 Suppl): 2161–2167.
  • Yıldırım E, Kormi I, Başoğlu ÖK, Periodontal health and serum, saliva matrix metalloproteinases in patients with mild chronic obstructive pulmonary disease. J Periodontal Res 2013; 48:269–275.
  • Zhang Y, Bunjhoo H, Xiong W, Xu Y, Yang D. Association between C-reactive protein concentration and chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Int Med Res 2012; 40:1629–1635.
  • Noack B, Genco RJ, Trevisan M, Grossi S, Jambon JJ. Periodontal infections contribute to elevated systemic C-reactive protein levels. J Periodontol 2001; 72:1221–1227.
  • Saito T, Murakami M, Shimazaki Y, Oobayashi K, Matsumoto S, Toshihiko K. Association between alveolar bone loss and elevated serum C-reactive protein in Japanese men. J Periodontol 2003; 74: 1741–1746.
  • D'Aiuto F, Parkar M, Andreou G, Periodontitis and systemic inflammation; Control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004; 83: 156–160.
  • Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008; 35:277–290.
  • Megson E, Fitzsimmons T, Dharmapatni K, Bartold PM. C-reactive protein in gingival crevicular fluid may be indicative of systemic inflammation. J Clin Periodontol 2010; 37:797–804.
  • Fitzsimmons TR, Sanders AE, Slade GD, Bartold PM. Biomarkers of periodontal inflammation in the Australian adult population. Aust Dent J 2009; 54:115–122.
  • Champagne CM, Buchanan W, Reddy MS, Preisser JS, Beck JD, Offenbacher S. Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases. Periodontol 2000 2003; 31:167–180.
  • Offenbacher SB, Odle M, Van Dyke TE. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Perio Res 1986; 21:101–112.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.